Cargando…
Tumor PKCδ instigates immune exclusion in EGFR-mutated non–small cell lung cancer
BACKGROUND: The recruitment of a sufficient number of immune cells to induce an inflamed tumor microenvironment (TME) is a prerequisite for effective response to cancer immunotherapy. The immunological phenotypes in the TME of EGFR–mutated lung cancer were characterized as non-inflamed, for which im...
Autores principales: | Zuo, Yi-Han, Gao, Wei-Na, Xie, Ya-Jia, Yang, Sheng-Yong, Zhou, Jin-Tai, Liang, Hai-Hai, Fan, Xing-Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733210/ https://www.ncbi.nlm.nih.gov/pubmed/36482371 http://dx.doi.org/10.1186/s12916-022-02670-0 |
Ejemplares similares
-
Phosphorylation of PKCδ by FER tips the balance from EGFR degradation to recycling
por: Lonic, Ana, et al.
Publicado: (2021) -
PKCα and PKCδ: Friends and Rivals
por: Black, Jennifer D., et al.
Publicado: (2022) -
PKCδ-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs
por: Chen, Chia-Hung, et al.
Publicado: (2021) -
Identification of lipocalin-2 as a PKCδ phosphorylation substrate in neutrophils
por: Weng, Yi-Chinn, et al.
Publicado: (2015) -
Differential Roles of the PKC Novel Isoforms, PKCδ and PKCε, in Mouse and Human Platelets
por: Pears, Catherine J., et al.
Publicado: (2008)